BRIGHTGENE

brightgene-logo

BrightGene Bio-medical technology Co.,Ltd., is a leading Chinese biopharmaceutical company in small molecules and nucleotide drugs areas. Advised by China-based venture capital fund Laurel Venture Capital, BrightGene invests in all stage therapeutics and innovations.

#SimilarOrganizations #People #Financial #More

BRIGHTGENE

Industry:
Biopharma Biotechnology

Founded:
2001-01-01

Status:
Active

Total Funding:
550 M CNY

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Content Delivery Network Domain Not Resolving Mobile Non Scaleable Content DigiCert SSL GeoTrust SSL Baidu Analytics


Similar Organizations

not_available_image

Brickcells Technologies

Brickcells Technologies is a Biopharma company.

enterin-logo

Enterin

Philadelphia-based biotechnology company .

not_available_image

Etern

Etern is a biopharma company.

frontier-biotechnologies-logo

Frontier Biotechnologies

Frontier Biotechnologies is a commercial-stage bio-pharmaceutical company.

innovent-biologics-logo

Innovent Biologics

Innovent Biologics is a biopharmaceutical company that develops and manufactures monoclonal antibodies.

minerva-neuroscience-logo

Minerva Neuroscience

Minerva Neurosciences is a clinical-stage biopharmaceutical company

ocugen-logo

Ocugen

Ocugen is a clinical stage biopharmaceutical company.


Current Advisors List

not_available_image

Jiandong Yuan Chairman @ BrightGene
Board_member

Current Employees Featured

not_available_image

Yuan Lai Zou
Yuan Lai Zou Chief Financial Officer @ BrightGene
Chief Financial Officer

Founder


not_available_image

Jiandong Yuan

Stock Details


Company's stock symbol is SSE:688166

Investors List

highlight-capital-llc_image

Highlight Capital

Highlight Capital investment in Venture Round - BrightGene

state-development-investment-corporation-sdic_image

State Development & Investment Corporation

State Development & Investment Corporation investment in Venture Round - BrightGene

gf-qianhe-investment_image

GF Qianhe Investment

GF Qianhe Investment investment in Venture Round - BrightGene

sequoia-capital-china_image

Sequoia Capital China

Sequoia Capital China investment in Venture Round - BrightGene

Investments List

Date Company Article Money raised
2020-07-02 Citryll BrightGene investment in Series B - Citryll 18.5 M EUR
2019-07-03 Citryll BrightGene investment in Series A - Citryll N/A
2018-08-08 DNALite Therapeutics BrightGene investment in Seed Round - DNALite Therapeutics 1.5 M USD

More informations about "BrightGene"

About Us - BrightGene Health

BrightGene Health builds on decades of microbial research and development achievements from BrightGene Bio-Medical. Adhering to the principle of independent innovation, it places great …See details»

BrightGene - Crunchbase Investor Profile & Investments

BrightGene Bio-medical technology Co.,Ltd., is a leading Chinese biopharmaceutical company in small molecules and nucleotide drugs areas. Advised by China-based venture capital fund Laurel Venture Capital, …See details»

BrightGene

BrightGene Bio-Medical Technology Co., Ltd (stock code: 688166) is an innovative pharmaceutical enterprise participating in international competition. Relying on R&D drive, the …See details»

China API and Intermediate, Formulation, Cosmetic …

BrightGene Bio-Medical Technology Co., Ltd is a high-end pharmaceutical company with high-barrier intermediates and APls as its core. Founded in 2001, the company has accumulated more than 20 years in the field of characteristic …See details»

力行求是,勇于创新 - BrightGene

After years of continuous R&D and exploration,BrightGene has made breakthroughs in the fields of tumor targeted therapy and immunotherapy, as well as the treatment of fatty liver and diabetes. Many original new drugs have …See details»

BrightGene Bio-Medical Technology Company Description - Stock …

5 days ago Company profile for BrightGene Bio-Medical Technology Co., Ltd. (SHA: 688166) with a description, list of executives, contact details and other key facts.See details»

BrightGene

As the inventor of 269 patent applications (by the end of 2021), Dr. Yuan Jiandong, who led the research and development of several patent technologies of BrightGene, won the "China Patent Award" for "the synthesis method of …See details»

BrightGene - Investments, Portfolio & Company Exits - Crunchbase

Jan 29, 2024 BrightGene has made 4 investments. Their most recent investment was on Jan 29, 2024, when Aoli Biotechnology raised. How many investments has this organization made …See details»

BrightGene Company Profile - Office Locations, Competitors

Oct 29, 2024 BrightGene (博瑞生物医药) is a research-driven biopharmaceutical company that engages in the R&D and manufacturing of medicines. Its products include immuno-oncological …See details»

BrightGene (688166.SH)-Starquest Capital

BrightGene (688166.SH) Founded in October 2001, BrightGene Bio-Medical Technology Co.,Ltd. is a research-driven high-tech pharmaceutical company dedicated to the research and …See details»

BrightGene - VentureRadar

BrightGene Bio-Medical Technology Co., Ltd. specializes in the research, development, and manufacturing of innovative pharmaceutical products. The company is dedicated to advancing …See details»

BrightGene Bio-Medical Technology Co Ltd: Executives - GlobalData

The following section provides information on BrightGene Bio-Medical Technology Co Ltd’s senior management, executives, CEO and key decision makers and their roles in the organization. …See details»

BrightGene Bio-Medical Technology Company - PitchBook

BrightGene Bio-Medical Technology Company General Information Description. Brightgene Bio-medical Technology Co Ltd is a pharmaceutical company engaged in research, development …See details»

BrightGene

To provide patients with high-quality drugs, reduce their economic burden, solve their pain, bring hope for their lives, and benefit the societySee details»

BrightGene - Funding, Financials, Valuation & Investors - Crunchbase

BrightGene is registered under the ticker SSE:688166 . Their stock opened with CN¥12.71 in its Nov 8, 2019 IPO. ... How much funding has this organization raised over time? Show . …See details»

BrightGene Bio-Medical Technology Co., Ltd - Sinodo Surgical …

BrightGene Bio-Medical Technology Co., Ltd. (stock code: 688166) is a global, innovative pharmaceutical company focused on R&D-driven emerging technology and the global market. …See details»

BrightGene Bio-Medical Technology Co.,Ltd DMF, CEP, Written ...

BrightGene Bio-Medical Technology Co.,Ltd// BrightGene Bio-Medical Technology Co., Ltd. is a research driven biopharmaceutical company that engages in the R&D and manufacturing of …See details»

Introduction of BrightGene-Abby | PPT - SlideShare

Sep 22, 2016 5. Introduction-Milestone 2001 BrightGene Bio-Medical founded by Dr.Yuan 2006 BrightGene developed a non-infringing process of Entecavir 2010 BrightGene …See details»

Four manufacturers sign sublicence agreements with the …

Jun 22, 2023 Geneva – The Medicines Patent Pool (MPP) announced today that it has signed sublicence agreements with three India-based companies, Eugia, Hetero and Dr. Reddy’s …See details»

BrightGene Bio-Medical Technology Co., Ltd. ESG Risk Rating

Brightgene Bio-medical Technology Co Ltd is a pharmaceutical company engaged in research, development and production of new drugs and high-end generic drugs. ... can be used to …See details»

linkstock.net © 2022. All rights reserved